Preparation method of non-fusion anti-desmoglein DSG3 rabbit-derived monoclonal antibody
A technology of desmoglein and monoclonal antibody, which is applied in the field of monoclonal antibody preparation, can solve the problems of lack of industrial reproducibility, restrictions on the industrial production and application of antibodies, and the inability to carry out antibodies.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] This example provides a specific preparation method of non-fused anti-desmoglein DSG3 rabbit-derived monoclonal antibody, specifically as follows:
[0064] 1. Immunization and blood test of DSG3
[0065] The immunized animals are healthy male New Zealand white rabbits aged about three months and weighing about 2.5kg, and the animals are immunized with special antigens. Specific steps are as follows:
[0066] Before the first immunization, blood was taken from the ear vein as a negative control. Take 500 μg of antigen, then add an equal volume of Freund’s complete adjuvant (after mixing and emulsification) for the first immunization, and mix an equal volume of 250 μg of antigen with Freund’s incomplete adjuvant (after mixing and emulsification) for the second to fourth Immunization. Rabbits were injected subcutaneously at limbs, underarms and back at multiple points, and the second immunization was performed three weeks after the first immunization, and a booster was ...
Embodiment 2
[0086] In this example, using the antibody preparation method described in the above example, two monoclonal antibodies of DSG3 rabbit origin were obtained: antibody 1C2 and antibody 1A4, against these two antibodies and coated DSG3, as well as irrelevant protein 1 and irrelevant protein 2 The antigen-coated plate was subjected to indirect enzyme-linked immunoreaction (ELISA method) to verify its specificity results.
[0087] The DSG3 rabbit-derived monoclonal antibody was diluted to different ratios for testing, and the results were as follows: figure 1 , figure 2 shown. The results showed that after antibody 2 3 After one-fold dilution, the binding responses of DSG3 rabbit monoclonal antibodies 1C2 and 1A4 to DSG3 were significantly different from those of unrelated proteins, and this difference existed until antibody 2 8 in the dilution results. It shows that both antibody 1C2 and antibody 1A4 only have specific adsorption reaction to DSG3 antigen.
Embodiment 3
[0089] In this example, a histoimmunochemical verification experiment was carried out for the prepared DSG3 rabbit-derived monoclonal antibodies 1C2 and 1A4, as follows:
[0090] The DSG3 rabbit monoclonal antibody 1C2, 1A4 was detected by immunohistochemistry under the gradient, and the positive serum was used as the antibody control, and the HRP color development results were as follows: image 3 shown.
[0091] Experimental conclusion, the immunohistochemical detection trend of DSG3 rabbit monoclonal antibody 1C2 and 1A4 in cervical cancer, skin cancer, colon cancer and gastric cancer is consistent with the positive serum, and the expression of DSG3 antigen protein is higher in cervical cancer and skin cancer expression in colon and gastric cancer.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com